For example, tumors characterized by a dense desmoplastic reaction, such as sarcomas, pancreatic cancers, and lung adenocarcinomas, demonstrate robust FAP expression which results in high tumor-to-background contrast that may surpass the performance of FDG PET [170]. This evidence concerns the gene FAP and sarcoma.